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Abstract
In proliferating C C myoblasts, serum and physiological concentrations of insulin and IGF-I stimulated protein2 12
synthesis and RNA accretion. After fusion, the multinucleated myotubes remained responsive to serum but not to insulin or
IGF-I, even though both insulin and type-1 IGF receptor mRNAs increased in abundance. Protein synthetic responses to
insulin and IGF-I in myoblasts were not inhibited by dexamethasone, ibuprofen or Ro-31-8220, thus phospholipase A ,2
cyclo-oxygenase and protein kinase C did not appear to be involved in the signalling mechanisms. Neither apparently were
polyphosphoinositide-specific phospholipase C or phospholipase D since neither hormone increased inositol phosphate,
phosphatidic acid, choline or phosphatidylbutanol production. Only the phosphatidylinositol-3-kinase inhibitor, wortmannin,
and the 70 kDa S6-kinase inhibitor, rapamycin, wholly or partially blocked the effects of insulin and IGF-I on protein
synthesis. 2-deoxyglucose uptake remained responsive to insulin and IGF-I after fusion and was also inhibited by
wortmannin. The results suggest that the loss of responsiveness after fusion is not due to loss of receptors, but to the
uncoupling of a post-receptor pathway, occurring after the divergence of the glucose transport and protein synthesis
signalling systems, and that, if wortmannin acts at a single site, this is prior to that point of divergence.
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1. Introduction
Following the loss of skeletal muscle through in-
jury or disease, new fibres can be formed by prolifer-
w xation, fusion and maturation of satellite cells 1,2 .
An understanding of the mechanisms regulating these
processes may be of great benefit in combatting the
effects of sepsis and trauma and in states such as
cachexia. To investigate these events we have used
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the pure, immortalised mouse satellite cell line, C C2 12
w x3 , which is morphologically similar to primary satel-
w xlite cell cultures 4 . Using these cells in the unfused,
myoblast state, we have shown that protein and DNA
synthesis are stimulated by Epidermal growth factor
 .  .EGF , basic Fibroblast growth factor bFGF , 12-O-
 .tetradecanoylphorbol 13-acetate TPA and exoge-
 .nous phospholipase D PLD and that PLD-depen-
dent and independent pathways are involved in these
w xevents 5 .
Knowledge of the pathways which control protein
synthesis and hypertrophy following fusion of my-
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oblasts into multinucleated myofibres is equally im-
portant in assessing a cell line as a model for myoge-
nesis. The C C cell line forms myotubes in culture2 12
w xand can participate in muscle regeneration in vivo 6 .
However, we have shown that, upon differentiation,
the protein synthetic response to EGF, bFGF, TPA
w xand PLD is lost 5 . This is not surprising with regard
to EGF and bFGF as receptors for both are perma-
nently down-regulated during terminal differentiation
of several skeletal muscle cell lines, including C C2 12
w xcells 7 . In contrast, both TPA and PLD elicit second
messenger production in C C myotubes suggesting2 12
that uncoupling occurs downstream of the receptor
w x5 .
Mature skeletal muscle is one of the major targets
for action of anabolic hormones such as insulin and
 .insulin-like growth factor-I IGF-I . For example, in
vivo, muscle protein synthesis is highly sensitive to
physiological concentrations of insulin in overnight-
w xfasted rats 8 , whilst studies in vitro have demon-
strated that insulin is mitogenic at high concentra-
w xtions 9 , and affects cell metabolism and stimulates
protein synthesis at a concentration closer to the
w xphysiological range in isolated muscle 10 and in L6
w xmyoblasts 11 . Furthermore, unlike the receptors for
EGF and bFGF, those for insulin and IGF-I increase
w xupon fusion 12–14 , suggesting an important role for
these two agonists, in keeping with their function in
vivo. Studies both in vivo and in vitro have impli-
 .cated phospholipase A PLA and the release of2 2
arachidonic acid in the stimulation of muscle protein
synthesis by insulin. Conversion of arachidonate to
cyclo-oxygenase metabolites appears to play an im-
portant role in the control of translation in isolated
w x w xmuscle 10 and in L6 myoblasts 15 , whereas
 .arachidonate activation of protein kinase C PKC
may be the mechanism by which insulin stimulates
w xtranscription in L6 cells 16 . Thus skeletal muscle
and the L6 cell line have similarities in their insulin
signal transduction pathways. In other respects, such
as the extent to which fusion occurs, the C C line2 12
may be a preferable model.
The aims of this study were to investigate the
ability of insulin and IGF-I to stimulate protein syn-
thesis in C C cells before and after fusion and to2 12
evaluate the suitability of the C C cell line as a2 12
model for the action of anabolic hormones in skeletal
muscle by determining if the signal transduction
mechanisms involved in the action of insulin and
IGF-I are the same as those employed in L6 my-
oblasts and intact muscle.
2. Materials and methods
2.1. Materials
w  . 3 x w 3 x9,10 n - H oleic acid, methyl- H choline chlo-
w3 x w 3 x w14 xride, H inositol, L- 2,6 H phenylalanine, C 2-de-
oxy-D-glucose, gamma-CT32P, Hyperfilm MP and
Megaprime random priming kit were from Amer-
 .sham International Amersham, Bucks., UK . Other
suppliers were: EN3HANCE spray, N.E. Technolo-
 . gies Stevenage, Herts., UK ; IGF-I, Bachem Saf-
.fron Walden, Essex, UK ; insulin, human actrapid,
 .Novo Nordisk ArS Bagsvaerd, Denmark ; Silica gel
 .60 A K6 plates, Whatman Maidstone, Kent, UK ;
Ultima Gold Scintillation fluid, Packard Pangbourne,
.Berks., UK ; tissue culture plasticware, Greiner
 .Dursley, Glos., UK ; Superscript reverse transcrip-
tase and all media and sera, GibcorBRL Life Tech-
 .nologies Paisley, Scotland ; Ro-31-8220 and ra-
 .pamycin Calbiochem Beeston, Notts., UK . All other
 .chemicals were from Sigma Poole, Dorset, UK .
2.2. Protein synthesis, RNA accretion, and second
messenger production
 .C C cells American Type Culture Collection2 12
were grown on 60 mm Petri dishes in 2.5 ml of
 .Dulbecco’s modified Eagle’s medium DMEM
w xq12% foetal calf serum 17 . They were used either
before the onset of fusion, when approx. 75% conflu-
ent, or 4–5 days after the onset of fusion, induced by
incubation with DMEM q10% horse serum. Before
each experiment, subconfluent or fused cells were
stepped down to 2 ml of serum-free DMEM. Then,
18 h later, insulin, IGF-I or TPA were added for up
to 6 h and at concentrations described in the text.
Dexamethasone was dissolved in ethanol and added
to give a final concn. in the medium of 100 nM, it
was added 18 h before insulin, i.e. when the medium
was changed, because its inhibitory effects are not
w xapparent in the short term 18 . All other inhibitors,
 .ibuprofen in ethanol, final concn. 1 mM ; Ro-31-
 .8220 in DMSO, final concn. 1 mM ; wortmannin
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 .and rapamycin both in DMSO, final concn. 100 nM
were added 10 min before insulin or IGF-I. Equal
 .volumes maximally 4 ml of carrier were added to
controls. Protein synthesis was measured by adding
w 3 xL- 2,6 H phenylalanine for the final 60 min of incu-
w xbations 19 . This method, a modification of a tech-
w xnique widely used in vivo 20 involves elevating the
phenylalanine concentration of the medium by adding,
per ml of medium, 750 nmol L-phenylalanine specific
radioactivity 3,000 dpmrnmol. 60 min later cells
were rapidly washed 3 times in ice-cold PBS, pH 7.4.
Protein bound and free intracellular phenylalanine
were separated by incubating the cells in each dish in
1 ml of 0.3 M-NaOH at 378C for 30 min. Protein was
then precipitated with 0.5 ml of 2 M perchloric acid.
Following centrifugation, the supernatant was used to
w xdetermine total RNA 21 and the pellet was washed
twice in 0.2 M-PCA, redissolved in 1 ml of 0.3
M-NaOH and aliquots were analysed for total protein
w xcontent 22 and by scintillation counting to deter-
 .mine the specific radioactivity d.p.m.rmg protein .
 .Measurements of total inositol phosphates IP ,
 .phosphatidic acid PA , phosphatidylbutanol
 .PtdBuOH and choline release were performed as
w xdescribed previously 5,19 , on cells prepared as above
and labelled for 18 h in serum-free medium with
w3 x w3 x w3 xH inositol, H oleic acid or H choline chloride,
respectively.
2.3. 2-Deoxyglucose uptake
For glucose uptake experiments, cells were grown
under the same conditions but medium was replaced
w x with 2 mls Kreb’s-Ringer phosphate 23 . Insulin 0.5
.  .nM–1 mM or IGF-I 1–100 nM , 20 ml of a
 .solution containing 2-deoxyglucose 10 mCi per ml
 .and glucose final concn. 5 mM were added. Uptake
of glucose was measured over periods of 15 min-1 h,
after which the cells were washed 3 times in ice-cold
PBS, solubilised in 0.3 M-NaOH and uptake was
determined by scintillation counting.
2.4. Extraction and resolution of mRNAs and North-
ern blotting
Cells were grown in 90 mm dishes containing 8 ml
medium. Either before or after fusion, induced as
w xdescribed above, total RNA was extracted 24,25 and
 .RNA 20 mg was resolved in a 1.2% agarose gel
containing formaldehyde and transferred to a nylon
 .membrane Genescreen, Dupont by overnight capil-
lary blotting. Two cDNAs; a 1.5 kb EcoRIrPstI
fragment of the human insulin receptor gene corre-
sponding to 1,101–2,602 which can be found in the
w xextracellular domain 26 and a 2 kb Bgl II fragment
w xof the human GLUT-1 gene 27 were then labelled
with gamma-CT32P using the Megaprime random
w xpriming kit. After Northern hybridisation 24 , the
membranes were exposed to pre-flashed autoradiog-
 .raphy film Hyperfilm MP; 10 days at y708C .
2.5. Re˝erse transcriptase polymerase chain reaction
( )RT-PCR
cDNAs were prepared from 5 mg of total RNA
using an oligo-dT-primer and Superscript reverse
transcriptase. The respective cDNAs were then am-
plified using specific primers IGF-1 forward primer
CTCGGATCCTCCTCGCATCTCTTCTACC; re-
verse primer CTCAAGCTTCTTGTTTCCTG-
CACTCCCTC: IGF-1 receptor forward primer GC-
CTCTCCGGGTTTGAAAATG; reverse primer
.CCGGAGCCAGACTTCATTCCT and the resulting
PCR products were resolved in a 1.8% agarose gel,
stained with ethidium bromide and visualised under
ultraviolet light. PCR products of 381 bp and 333 bp
were obtained using the IGF-1 and IGF-1 receptor
specific primers, respectively.
2.6. Statistics
Each experiment was performed 2 or 3 times, with
4 or 5 replicates per treatment. Data were analysed by
two way analysis of variance using set as a blocking
.factor with the Genstat 5 version 3.1 statistics pack-
age. Results of experiments which were not signifi-
cantly different were combined and a Student’s t-test
was used to assess the level of significance of effects
of the various agonists.
3. Results
3.1. Protein synthesis
When protein synthesis was measured in subcon-
fluent myoblasts during the final hour of a 6 h
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Table 1
Effect of 6 h exposure to insulin and IGF-I on protein synthesis and RNA accretion in fused and unfused C C cells2 12
Protein-bound phenylalanine — specific radioactivity
Unfused Fused Unfused Fused
 .  .  .  .dpmrmg protein dpmrmg protein RNA; mgrdish RNA; mgrdish
Control 9.2"0.2 10.2"0.3 25.8"1.7 114.6"2.4
Insulin
)))0.5 nM 11.1"0.2 10.5"0.3 28.2"2.0 113.4"2.5
))) ))5 nM 12.4"0.1 10.7"0.4 36.8"1.9 114.6"1.9
))) )))50 nM 13.4"0.2 10.8"0.3 37.5"0.7 115.2"1.7
))) )))500 nM 14.6"0.2 10.6"0.2 44.1"0.7 113.8"0.8
))) )))1 mM 14.6"0.4 10.1"0.4 44.0"1.0 117.4"2.2
IGF-I
))) )1 nM 12.9"0.3 10.6"0.2 29.5"0.5 113.4"0.6
))) )))5 nM 13.8"0.1 10.1"0.2 34.8"0.6 116.0"2.1
))) )))100 nM 14.1"0.2 10.4"0.3 37.9"0.6 117.0"2.0
))) ))) )))12% FCS 14.8"0.1 15.3"0.3 29.5"0.3 116.5"1.1
 .Cells were used either before reaching confluence or 4–5 days after the onset of fusion. Insulin, IGF-I or foetal calf serum FCS were
w3 xadded for 6 h, incorporation of H phenylalanine into protein was measured over a 1 h period commencing 5 h after adding the agonist.
 .Values are means of 10 replicates "S.E.M. 2 identical experiments each with ns5 .
 . ) )) )))Significance of differences by Student’s t-test ; , , ; P-0.05, 0.01, 0.001 vs. control, respectively.
incubation, insulin at a concentration of 0.5 nM a
.value close to the physiological range; ca 70 mUrml
w3 xincreased H phenylalanine incorporation by 21%.
Higher concentrations of insulin induced greater
stimulation of both protein synthesis and RNA accre-
tion 46% and 45%, respectively, at 50 nM; 59% and
.71%, respectively, at 1 mM; Table 1 . IGF-I gave
similar results, increasing protein synthesis by 53%
and RNA accretion by 47% at the highest concentra-
 .tion 100 nM .
In differentiated cells, used 4–5 days after the
onset of fusion, all these effects were lost, neither
insulin nor IGF-I stimulated protein synthesis or RNA
 .accretion Table 1 . However the ability to respond to
repletion with foetal calf serum was not lost, protein
synthesis was increased by 61% and 50% respec-
tively in the subconfluent and the fused cells Table
.1 .
 .Briefer 90 min exposure to 0.5 nM insulin stimu-
lated protein synthesis in the unfused myoblasts by
19% and 1 nM IGF-I gave an 18% increase Table
.  .2 . Higher concentrations of insulin 5 and 50 nM
and 5 nM IGF-I enhanced protein synthesis further,
from 9.0"0.2 to 11.8"0.1, 12.0"0.3 and 12.2"
 .0.1 respectively all ns10; P-0.001 . Thus the
maximal increase in protein synthesis induced by
insulin was 32% and by IGF-I was 34%.
Again, after fusion to myotubes the ability to
respond to 0.5 nM insulin and 1 nM IGF-I was lost
 .Table 2 . Higher concentrations were equally inef-
fective; 5 and 50 nM insulin and 5 nM IGF-I gave
specific radioactivities of 9.6"0.2, 9.9"0.2 and
 .10.0"0.4 respectively all ns10 and not signifi-
 .cantly different from the control 10.0"0.3 .
3.2. Insulin and type-I IGF receptor and IGF-I mR-
NAs
The second series of experiments was designed to
investigate the possibility that the loss of response
Table 2
Effect of 90-min exposure to insulin and IGF-I on protein





) .Insulin 0.5 nM 10.8"0.3 9.6"0.3
) .IGF-I 1 nM 10.7"0.3 10.1"0.3
Details as in Table 1 but insulin or IGF-I were added for 90 min,
phenylalanine incorporation was measured over a 1-h period
commencing 30 min after adding insulin. Values are means of 10
 .replicates "S.E.M. 2 identical experiments each with ns5 ;
)
, P -0.001 vs. control.
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 .Fig. 1. Northern hybridisation of total RNA with a insulin
 .receptor and b GLUT-1 specific cDNAs. Results are shown for
 .total RNA 20 mg extracted from triplicate cultures of subcon-
 .fluent myoblasts lanes 1,3,5 or myotubes, 5 days after the onset
 .of fusion lanes 2,4,6 .
related to a loss of insulin and IGF-I receptors.
However, a Northern blot of the insulin receptor
 .mRNA Fig. 1A revealed that it had increased
markedly on fusion. Furthermore, mRNAs for the
IGF-I receptor and IGF-I itself were both detected by
RT-PCR in the cells before and after fusion and
whilst the IGF-I mRNA changed little in abundance
 .on fusion Fig. 2A , the type 1-IGF receptor mRNA,
like that for the insulin receptor, increased in the
 .differentiated cells Fig. 2B .
3.3. Glucose transport
Additional evidence for the presence of receptors
was provided by the observation that not all of the
metabolic responses to insulin and IGF-I were lost on
Fig. 2. RT-PCR of the IGF-I and type 1 IGF receptor specific
 .genes. Messenger RNAs for IGF-I A and the type 1 IGF-I
 .receptor B were detected by visualisation of a specific PCR
product in triplicate cultures of subconfluent myoblasts lanes
.  .1,2,3 or myotubes, 5 days after the onset of fusion lanes 4,5,6 .
Table 3
Effect of insulin and IGF-I on 2-deoxyglucose uptake in fused
and unfused C C cells2 12
Glucose uptake, cpmrmg protein
Unfused Fused
 .  .Control 78"4 12 9.2"0.2 12
Insulin
)) ) .  .0.5 nM 98"5 12 10.3"0.5 12
))) ))) .  .5 nM 110"4 8 12.2"0.6 12
))) ))) .  .1 mM 122"4 8 13.9"0.2 8
IGF-I
))) )) .  .1 nM 120"5 8 11.9"0.9 12
))) ))) .  .5 nM 119"5 12 12.4"0.5 8
))) ))) .  .100 nM 124"3 8 13.9"0.5 8
))) ))) .  .100 nM Wortmannin 47"6 8 4.7"0.3 8
 .  .Insulin 5 nM q 53"2 8 5.1"0.2 8
100 nM Wortmannin
Medium was replaced with 2 ml Kreb’s-Ringer phosphate and
experiments were performed 1 h later by adding insulin 0.5 or 5
.  .nM or IGF-I 1 or 5 nM and 20 ml of a solution containing
 .2-deoxyglucose 10 mCirml and glucose to obtain a concentra-
tion in the medium of 5 mM. Values are means "S.E.M. for the
no. of replicates shown in parentheses two or three identical
.experiments each with 4 dishes of cells .
 . ) )) )))Significance of differences by Student;s t-test ; , , ;
P -0.05, 0.01, 0.001 vs. control, respectively.
fusion. In myotubes, in sharp contrast to the response
of protein synthesis, insulin and IGF-I both signifi-
cantly increased glucose transport both by 51% at
the maximum concentration in a 1 h incubation;
.Table 3 . The linearity of the response was examined
by measuring glucose transport after 15 and 30 min.
Increases of 37"1% and 57"3% were obtained at
 .15 and 30 min respectively both ns8, P-0.01 .
To compare the time-course of effects on protein
synthesis under similar conditions, protein synthesis
was measured 15 and 30 min after adding insulin 1
. w3 xmM and H phenylalanine simultaneously. Insulin
increased phenylalanine incorporation from 2.6"0.1
to 3.9"0.1 d.p.m. per mg of protein at the end of a
15-min incubation; corresponding values at 30 min
were 4.9"0.1 and 7.1"0.2 d.p.m. per mg all
.P-0.001; ns8 .
3.4. PLA , cyclo-oxygenase and PKC inhibition2
In the third series of experiments, the potential role
of a number of signal transduction pathways was
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Table 4
Effect of dexamethasone, ibuprofen, Ro 31-8220, wortmannin and rapamycin on the stimulation of protein synthesis in C C myoblasts2 12
by insulin and IGF-I
 .Specific radioactivity dpmrmg protein
Addition control 0.5 nM insulin 1 nM IGF-I
))None 16.3"0.2 18.9"0.2 n.d.
†† ) )Dexamethasone 100 nM 14.9"0.1 17.3"0.3 n.d.
)) ))None 16.5"0.4 19.5"0.2 19.6"0.2
)) ))Ibuprofen 1 mM 16.8"0.3 18.9"0.3 19.3"0.3
)) ))None 14.9"0.3 17.4"0.2 17.3"0.2
†† ) ) ) )Ro 31-8220 1 mM 12.6"0.2 14.8"0.3 14.7"0.5
))None 15.8"0.5 19.7"0.1 n.d.
†Wortmannin 100 nM 13.6"0.5 14.9"0.3 n.d.
)) ))None 17.0"0.4 21.7"0.6 21.2"0.3
†† )Rapamycin 100 nM 15.3"0.8 18.1"0.2 17.9"0.4
Dexamethasone was added to sub-confluent cultures in serum free DMEM 18 h before insulin. Ibuprofen, Ro-31-8220, wortmannin or
w3 xrapamycin were added 10 min before insulin or IGF-I which were added for 6 h, incorporation of H phenylalanine into protein was
measured over the final 1 h
 .Values are means of 10 replicates "S.E.M. 2 identical experiments each with ns5 . Significance of effect of insulin or IGF-I vs.
corresponding control "inhibitor ), )) P-0.01, P-0.001. Significant inhibition of basal rate of protein synthesis †, ††; P-0.05,
P-0.001.
investigated, firstly, by examining effects of specific
inhibitors on the stimulation of protein synthesis.
Dexamethasone, an inhibitor of PLA , did not2
inhibit the ability of insulin to stimulate protein syn-
thesis in the unfused cells, whilst ibuprofen, a cyclo-
oxygenase inhibitor, and the PKC inhibitor, Ro-31-
8220, also failed to block the effects of either agonist
 .Table 4 .
Lack of involvement of PLA was also indicated2
by the failure of insulin or IGF-I to increase glyc-
erophosphocholine release during a 30-min incuba-
tion 542"60 and 518"28, respectively; controls
.536"24; ns4 .
3.5. Metabolites of phospholipases C and D
The involvement of polyphosphoinositide-specific
 .phospholipase C PI-PLC and PLD in the response
of myoblasts to insulin and IGF-I was also investi-
 .gated by measuring metabolites of PI-PLC i.e., IP
 .and of PLD PA and choline . Production of the
stable transphosphatidylation product, PtdBuOH, in
the presence of 0.5% butanol was also measured.
Neither insulin nor IGF-I increased IP production,
whereas AlFy, an activator of G-proteins coupled to4
 .PI-PLC, gave a 177% increase Table 5 . Similarly,
insulin and IGF-I both failed to increase the produc-
tion of PtdBuOH or PA or the release of choline,
whilst TPA, used as a positive control to stimulate
PLD, elicited a more than 20-fold increase in Ptd-
BuOH and increases of 40% and 80%, respectively,
 .in PA and choline release Table 5 .
3.6. In˝ol˝ement of 70 kDa S6-kinase and phos-
phatidylinositol-3-kinase
Two inhibitors did affect the ability of insulin to
stimulate protein synthesis. A partial inhibition of the
response was obtained with rapamycin, an inhibitor
 S6K .of the 70 kDa S6-kinase p70 ; Table 4 . Insulin
stimulation was decreased from 28% in the absence
of rapamycin to 18% in its presence. IGF-I-induced
stimulation was also reduced, from 25 to 17% Table
.4 . Complete inhibition was obtained with wortman-
nin, an inhibitor of phosphatidylinositol-3-kinase PI-
.3 kinase . This was apparently not due to a general
toxic effect of wortmannin as the basal rate of protein
synthesis was reduced by only 12–17%. As further
evidence for a specific effect of wortmannin, the
ability of 1 nM TPA to stimulate protein synthesis
during a 90-min incubation was undiminished by this
inhibitor TPA increased the specific radioactivity of
protein-bound phenylalanine from 19.9"0.4 to 22.8
"0.4 d.p.m.rmg in the absence of wortmannin and
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Table 5
Release of metabolites of PI-PLC and PLD in response to insulin and IGF-I
Total dpm released
Inositol phosphates Choline PA PtdBuOH
Control 1364"110 1 298"45 10 993"463 1 942"456
Insulin 1536"84 1 157"94 11 985"464 1 954"296
IGF-I 1486"88 1 457"150 11 267"376 1 704"272
y )AlF 3784"183 1 508"84 12 274"376 1 897"844
) ) )TPA n.d. 2 371"158 15 336"655 42 807"4 310
w3 x w3 x w3 xCells were labelled for 18 h in serum free medium with H inositol, H choline chloride or H oleic acid. Release of metabolites was
measured over a 30-min period following addition of 0.5 nM insulin or 1 nM IGF-I. There were no significant effects of either agonist. 1
y  .nM TPA or AlF aqueous solutions of AlCl and NaF to give final concentrations of 100 mM and 10 mM respectively were used as4 3
 .positive controls. Values are means of 10 replicates "S.E.M. 2 identical experiments each with ns5 except for choline release data
where data are from a single experiment, ns5; by Student’s t-test ), P-0.001.
.from 16.7"0.7 to 19.4"0.3 in its presence . Wort-
mannin also inhibited glucose uptake, reducing the
basal rate by 60% and 50%, respectively, in the
unfused and fused cells, and completely blocking the
ability of insulin to stimulate glucose uptake in both
 .myoblasts and myotubes Table 3 .
4. Discussion
Insulin and IGF-I both induced a significant in-
crease in protein synthesis in myoblasts within 90
min, an effect which was probably due to an increase
in the rate of translation, since it was not blocked by
w xactinomycin D 5 . Similar effects were observed at
the end of a 6 h incubation, by which time the
enhanced phenylalanine incorporation was accompa-
nied by an increase in RNA content of the cells
suggesting that the effects were due, at least in part,
to an increase in transcription. The complete inability
of insulin and IGF-I to increase protein synthesis
after fusion, suggests that both agonists lose their
ability to stimulate transcription and translation fol-
lowing differentiation.
It has previously been shown that fusion of C2
cells results in a 5- to 10-fold increase in insulin
125 w xreceptor number and I-insulin binding 12 , whilst
terminal differentiation of BC3 H-1 myocytes results
in similar changes in insulin receptor number and
binding. Other studies in C cells have also shown2
increases in IGF-I mRNA, IGF-I itself and the num-
ber of both types of IGF receptor after differentiation
w x13,14 . Another widely used muscle cell line, L6,
also exhibited a two-fold increase in receptor number
and 125I-insulin binding as an early differentiation
w xevent 28 . In this latter case, the increase in insulin
receptor number correlated well with increased abil-
ity to stimulate glucose and amino acid uptake.
Therefore, although we have not demonstrated that
the mRNAs for the two receptors are being trans-
lated, published evidence, and that presented here,
suggests that the failure of insulin and IGF-I to
stimulate processes after fusion which they were
capable of increasing in the myoblast is not likely to
be due to a loss of the insulin or type 1 IGF recep-
tors. Nor is there any evidence to suggest autocrine or
paracrine effects of IGF-I after fusion, since the
IGF-I mRNA changed little, if at all, on fusion, and
glucose uptake remained sensitive to exogenous IGF-I
in the fused cells. This latter observation also sup-
ports the conclusion that functional receptors are not
lost following differentiation. Glucose transport is
probably mediated by translocation of GLUT 1 in
C rC cells, as it is in BC3H-1 myocytes, since2 12
w xboth these cell lines lack GLUT 4 23 . Stimulation of
glucose transport of similar magnitude to that found
in the present study has been reported previously in
w xdifferentiated C C cells 29 . Although there was2 12
little effect of fusion on the ability of insulin or IGF-I
to stimulate glucose uptake, it was noticeable that, in
sharp contrast to the essentially similar rates of pro-
tein synthesis before and after fusion, the unfused
cells had a basal rate of 2-deoxy glucose uptake per
unit of protein 9 times that in the myotubes. This
would appear to be consistent with the apparent
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reduction in the mRNA for GLUT 1 upon fusion
 .Fig. 1B .
To examine the possibility that, following fusion,
the persistence of the stimulation of glucose uptake
measured after 1 h, and the loss of the protein
synthetic effect, measured over a longer time period,
was due to degradation of the hormone, both mea-
surements were made 15 and 30 min after the addi-
tion of insulin. Using these same time periods, the
fact that the protein synthetic response was still ab-
sent, whilst the glucose transport effect appeared to
be approximately linear, suggests that insulin degra-
dation is not the reason for the different responses in
myotubes.
The fact that the rate of incorporation of phenyl-
alanine into protein was similar before fusion and
4–5 days after the onset of fusion, and that cells
responded to repletion with foetal calf serum at both
these times, makes the complete loss of response to
insulin and IGF-I surprising. Our data are in agree-
ment with the hypothesis that the insulin-insensitivity
of protein synthesis is probably due to events that
occur after receptor binding. In this respect, they
agree with the observation that glucocorticoid-in-
duced insulin resistance is due to a post-receptor
w x w xdefect 30 , possibly involving PKC 31 . The mito-
genic effects of insulin e.g. effects on creatine kinase
w xand DNA labelling 9 , like the effect on glucose
uptake reported here, either persist or increase on
fusion, again suggesting that the hormones still bind
to their receptors and therefore the loss of effects in
the present study is due to the uncoupling or loss of
part of the signal transduction mechanism. Several
possible such pathways have been investigated. Dex-
amethasone, an inhibitor of PLA , has been shown to2
inhibit the ability of insulin to stimulate protein syn-
w xthesis in L6 myoblasts 11 and in rat muscle in vivo
w x32 . Similarly, ibuprofen, a cyclo-oxygenase in-
hibitor, blocked the effect of insulin on translation in
w xL6 myoblasts 15 and other non-steroidal anti-in-
flammatory drugs such as indomethacin and meclofe-
namate have been shown to block insulin-stimulated
w xprotein synthesis in isolated muscle 10 and in vivo
w x33 . It was therefore surprising that, in the present
experiments, inhibition of PLA and cyclo-2
oxygenase, with dexamethasone or ibuprofen respec-
tively, was ineffective in blocking the effects of
insulin in C C myoblasts. Insulin also failed to2 12
activate PI-PLC or PLD although it has been shown
w xto stimulate PI-PLC in rat epididymal fat pads 34
w xand PLD in rat hepatocytes 35 . PI-PLC and PLD are
clearly present in C C cells as in both the present2 12
w x ystudy and in previous work 5 , AlF and TPA4
produced large increases in IP and PtdBuOH, respec-
tively.
We have previously shown that protein synthesis
in C C cells is stimulated by both PLD-dependent2 12
and -independent routes and demonstrated that EGF
and bFGF stimulation of protein synthesis is PLD-in-
w xdependent 5 . It is now apparent that the stimulation
of protein synthesis and RNA accretion by insulin in
this cell line is independent not only of PLD but of
PLA and PI-PLC as well. This prompted the series2
of experiments in which the involvement of PI-3
kinase was investigated. PI-3 kinase is considered to
play a pivotal role in insulin intracellular signalling
w x36 and wortmannin inhibits PI 3-kinase by associa-
w xtion with the 110 kDa catalytic subunit 37 . The
ability of wortmannin to block insulin stimulation of
both glucose uptake and protein synthesis in unfused
myoblasts could suggest that it is a non-specific
inhibitor, or that it acts on two PI-3 kinase isoforms
involved in these two signal transduction pathways.
With regard to protein synthesis, non-specific inhibi-
tion is unlikely as wortmannin did not block the
action of TPA. Furthermore, at the concentration
used here, its action seems to be specific as it does
w xnot inhibit phosphatidylinositol 4-kinase 38 , cyclic
w xnucleotide dependent kinases or PKC 39 . An alter-
native explanation is that a single PI-3 kinase is a
very early participant in the insulin signalling system,
acting before the glucose transport and protein syn-
thetic signals diverge. Previous published data sug-
gest that this is the case; PI3-kinase couples the
insulin receptor to downstream signalling compo-
nents thought to be involved in regulating protein
synthesis such as p70S6k and is also involved in the
w xtranslocation of glucose transporters 40,41 . In this
case, the ability of insulin to continue to stimulate
glucose uptake, and of wortmannin to block this in
the terminally differentiated myotube suggests that
the uncoupling of protein synthesis occurs after di-
vergence of the two pathways. The ability of ra-
S6k w xpamycin, an inhibitor of the p70 42 , to block the
effect of insulin by about 50%, suggests that this
enzyme and PI-3 kinase may be involved in a com-
( )R.M. Palmer et al.rBiochimica et Biophysica Acta 1355 1997 167–176 175
mon pathway by which insulin stimulates protein
synthesis in the C C myoblast.2 12
The C C cell line does not appear to be a good2 12
model for studying metabolic effects of anabolic
hormones such as insulin and the IGFs on skeletal
muscle, because insulin and IGF-I cease to stimulate
protein synthesis in fused myotubes and signalling
pathways involving PLA and cyclo-oxygenase which2
mediate insulin action in muscle do not appear to do
so in the C C cell.2 12
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